Hear your CEO debate other experts - with free food!

(Sponsored by Universities Allied for Essential Medicine, AMSA, MedEd)

Who:* CEO Ken Davis, Dean Charney, Jamie Love, Brook Baker, Bhaven Sampat and Robert Desnick

When: *Monday, June 1st at 5:30pm

Where:* Goldwurm Auditorium, Icahn Building; 1425 Madison Avenue (On the north east corner with East 98th street)

Why: *Biomedical policy greatly impacts public health,

*Big deal panelists*,*an interesting topic*, *free food*!

Our panelists include:

- Moderator: Dennis Charney - Dean of MSSM; Professor of Psychiatry
- Kenneth Davis - President/CEO of the Mount Sinai Medical Center; Professor of Psychiatry
- Brook Baker - Professor of Law, Northeastern University; Co- chair of HealthGAP; Consultant to African Union, WHO, ASEAN
- Bhaven Sampat – Assistant Professor, Department of Health Policy and Management, Columbia’s School of International and Public Affairs
- Jamie Love – Director of Knowledge Ecology International; Advisor to the X-Prize Foundation; Member of MSF Working Group on Intellectual Property
- Robert Desnick – Chairman of Department of Human Genetics,
> Mount Sinai;
> Director of Institute for Genomic Sciences, Mount Sinai; Scientific
> founder of Amicus Therapeutics
>
> Sponsored by: Universities Allied for Essential Medicines,
> American Medical
> Students Association, Department of Medical Education
>
> *Kenneth Davis’s* research on Alzheimer led to the development of
> cholinesterase inhibitors that effectively treat the symptoms of the
> disease. He demonstrated dopamine’s importance in the pathogenesis of
> schizophrenia. Currently he is the CEO and President of the Mount

> SinaiMedical Center. Link to extended
> biography
>
> *Dennis Charney* is one of the world's leading experts on the
> neurobiologyand treatment of serious mood and anxiety disorders. As

> Dean of the Mount
> Sinai School of Medicine, he increased the school’s focus on

> translationalresearch and has led an increase in the amount of NIH

> funding that the
> school receives. Link to extended

> biography
>
> *Brook Baker* is a legal scholar with expertise on intellectual
> propertyrights, health financing, and access to medicines. He is co-

> chair and policy
> analyst for Health GAP (Global Access Project). He has consulted
> for the
> African Union, ASEAN, Venezuela, CARICOM, Thailand, DfID, the World

> HealthOrganization, the Millennium Development Goals Project and

> others. He works
> on policy issues concerning the Global Fund to Fight AIDS,
> Tuberculosis and
> Malaria and the US PEPFAR Program. Link to extended

> biography
>
> *Bhaven Sampat* is an economist by training and is an expert on the

> intersection of health policy and innovation policy. His current

> projectsexamine the impacts of new global patent laws on innovation

> and access to
> medicines in developing countries, the political economy of the

> NationalInstitutes of Health, the roles of the public and private

> sectors in
> pharmaceutical innovation, and institutional aspects of patent
> systems. Dr.
> Sampat has also written extensively on the effects of university

> patentingand "entrepreneurship" on academic medicine. He is

> recipient of a Robert
> Wood Johnson Foundation "Investigator Award" to study how the NIH

> allocatesits funds across disease areas. Link to extended
> biography
>
> *James Love* is the Director of Knowledge Ecology International which

> received a MacArthur Award for Creative and Effective Institutions
> in 2006.
> He advises UN agencies, national governments, international and

> regionalintergovernmental organizations and public health NGOs, and

> is the author of
> a number of articles and monographs on innovation and intellectual

> propertyrights. Mr. Love is also the U.S. co-chair of the Trans-

> Atlantic Consumer
> Dialogue (TACD) Working Group on Intellectual Property, chair of

> EssentialInventions, an advisor to the X-Prize Foundation on a

> prize for TB
> diagnostics, and a member of the UNITAID Expert Group on Patent
> Pools, the
> MSF Working Group on Intellectual Property, the Stop-TB Partnership

> workinggroup on new drug development, and the Internet Governance

> Forum (IGF)
> Dynamic Coalition on Open Standards. Link to extended

> biography
>
> *Robert Desnick* is a professor and chair of the Department of

> Genetics and
> Genomics Sciences at Mount Sinai. He is a fellow of the American
> Academy for
> the Advancement of Science and a member of the Institute of
> Medicine of the
> National Academy of Sciences He is a past chair of the Association of
> American Medical Colleges. He is the scientific founder and a
> consultant to
> Amicus Therapeutics, Inc. He is a consultant and has a licensed
> patent for
> agalsidase beta with Genzyme Corp.
>

Attachment	Size
June1stPanelFlyer.ppt	449.5 KB